Table 1.
Baseline characteristics of the 102 heart failure patients
| Age | 75 ± 12 Years (47–91) |
|---|---|
| Gender | |
| Female | 61 (60 %) |
| Male | 41 (40 %) |
| Heart failure aetiology | |
| Ischaemic | 62 (61 %) |
| Non-ischaemic | 40 (39 %) |
| NYHA class | |
| II | 28 (27 %) |
| III | 57 (56 %) |
| IV | 17 (17 %) |
| eGFR | 49.0 ± 12.0 ml/min |
| Blood pressure/heart rate | |
| Systolic | 128.3 ± 16.1 mmHg |
| Diastolic | 77.6 ± 14.0 mmHg |
| Pulse | 73.4 ± 15.3 bpm |
| N-terminal pro-B-type natriuretic peptide | 4433 ± 5720 pg/l |
| Medications | |
| β-blockers | 82 (80 %) |
| Diuretics | 96 (94 %) |
| ACE inhibitors | 80 (78 %) |
| Implantable devices | 37 (36 %) |
| Affected valves | |
| Mitral | 89 (87 %) |
| Aortic | 16 (16 %) |
| Tricuspid | 59 (58 %) |
| Atrial fibrillation | 47 (46 %) |
NYHA New York Heart Association, eGFR estimated glomerular filtration rate, ACE angiotensin-converting enzyme